A new method for determining lung cancer risk could more efficiently identify individuals for annual screening and catch more cancers early, according to a study published in PLOS Medicine.
Scientists discover why bowel cancer sometimes outsmarts treatment
12/02/2014
A new study that challenges the prevailing view of how bowel cancer develops in the large intestine is published in Nature Medicine.
New cause of child brain tumour condition identified
12/02/2014
Doctors and scientists from The University of Manchester have identified changes in a gene, which can increase the risk of developing brain tumours in children with a rare inherited condition...
NICE reverses decision on access to new blood cancer drug
12/02/2014
NHS patients in England and Wales with chronic lymphocytic leukaemia (CLL) could soon benefit from Gazyvaro, which has today been given the provisional green light by the National Institute for...
Lack of follow-up care puts childhood cancer survivors at risk
12/02/2014
A presentation at the Clinical Oncology Society of Australia's (COSA's) Annual Scientific Meeting, will reveal that around two in five childhood cancer survivors are missing follow-up medical...
Exercise effective for bone cancer patients
12/02/2014
Findings being presented at the Clinical Oncology Society of Australia's (COSA's) Annual Scientific Meeting shows that traditional recommendations for cancer patients with bone metastases to avoid...
2D images as the new tool for cancer prevention
12/02/2014
Portuguese researchers have developed a new method, which from images of a protein in a population of cells quantifies its distribution (how much there is, and where in the cell) for that...
New substance overcomes treatment-restistance in leukaemia
12/02/2014
Haematologists from Goethe University Frankfurt, working with a Russian pharmaceutical company, have developed a new active substance that effectively combats the most aggressive forms of...
Mental health inequalities in detection of breast cancer
12/02/2014
Women with a mental illness (including depression, anxiety and serious mental illnesses) are less likely to be screened for breast cancer, according to new research published in the BJPsych.
Breast cancer: Endomagnetics receives IDE approval to initiate US trials
12/02/2014
Cancer healthcare company Endomagnetics has announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) to initiate a...